Genital warts caused by the human papillomavirus (HPV) are the most common sexually
transmitted disease and have a negative impact on quality of life. Of the more than 200 …

Human papillomavirus (HPV) is responsible for many types of extragenital cutaneous warts,
which remain among the leading reasons for dermatology visits. Warts are often recalcitrant …

Common cutaneous warts caused by human papillomavirus (HPV) strains 1, 2, and 4, can
be challenging to treat. Immunosuppressed patients are especially vulnerable to this …

Human papillomavirus (HPV) is ubiquitously distributed in the population worldwide and its
most frequent clinical presentation is cutaneous warts. Despite various treatment options …

Human papillomavirus (HPV) is an ancient stable DNA virus, which has evolved over
millennia and causes a variety of niche-specific cutaneous and mucosal infections and …

Background Despite the availability of different therapeutic modalities, treatment of
recalcitrant common warts is still challenging. Cervarix (GlaxoSmithKline, Brentford, UK), a …

Genital human papillomavirus (HPV) is a common, usually transient, dermatologic infection
transmitted by genital contact that can cause a variety of anogenital diseases, including …

Cutaneous and anogenital warts are the clinical manifestations of an infection with human
papillomaviruses (HPVs). There are more than 120 different HPV types. They are both very …

Background Human papillomavirus (HPV) infections are associated with common
dermatologic and nondermatologic diseases. Although HPV vaccines are well established …

Introduction: The human papillomavirus (HPV) vaccine has been reported to lead to clinical
clearance of lesions when used as an off-label treatment for recalcitrant extragenital warts …